← Back to Search

Other

Heat Patch Noncontinuous for Warts

N/A
Waitlist Available
Led By Richard Antaya, MD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 36 weeks
Awards & highlights

Study Summary

This trial will test aPatch that delivers heat to the skin to treat warts. The Patch will be applied to the skin for two hours. The trial will test the safety and efficacy of the Patch.

Eligible Conditions
  • Warts

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~36 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 36 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percent reduction in verrucae diameter - proof of concept study
Secondary outcome measures
Count of participants with an IGS score < = 2 on at least 1 non-target verruca - confirmation study
Count of participants with an IGS score < = 2 on target verruca - confirmation study
Count of participants with an IGS score = 0 on at least 1 non-target verruca - confirmation study
+1 more

Trial Design

2Treatment groups
Active Control
Group I: Heat Patch NoncontinuousActive Control1 Intervention
applied 2 hrs daily 2 weeks on and 2 weeks off for 12 weeks
Group II: Heat Patch ContinuousActive Control1 Intervention
applied 2 hrs daily for 12 weeks

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,852 Previous Clinical Trials
2,738,368 Total Patients Enrolled
Ferndale Laboratories, Inc.Industry Sponsor
4 Previous Clinical Trials
235 Total Patients Enrolled
Richard Antaya, MDPrincipal InvestigatorYale School of Medicine
1 Previous Clinical Trials
26 Total Patients Enrolled

Frequently Asked Questions

~6 spots leftby Apr 2025